Keywords
Latin America
T-Cell Project 2.0
How to Cite
Abstract
Mature T/NK lymphoid neoplasms (T-NHL) are infrequent and constitute a heterogeneous group of diseases. In Argentina and the rest of Latin America there is not any epidemiologic data about presentation, diagnostic methodology, therapies, and evolution of patients with T-NHL. Furthermore, because of their low incidence and heterogeneity, there are not prospective randomized trials assessing the different therapeutic strategies. The International T Cell Project 2.0 emerges with the aim of improving the understanding of these diseases. Herein its preliminary results to June 2021 are presented.
References
Swerdlow SH, Campo E, Pileri SA y col. The 2016 revision of the World Health) Organization classification of lymphoid neoplasms. Blood. 2016; 127(20):2375-2390.
Adams SV, Newcomb PA, Shustov AR. Racial patterns of peripheral T-Cell Lymphomas incidence and survival in the United States. J Clin Oncol. 2016;34(9):963-971.
Vose JM. Peripheral T-cell non-Hodgkin’s lymphoma. Hematol Oncol Clin North Am. 2008;22(5):997-1005.
Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-30.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar